Coregulators of VDR-mediated gene expression

Vitamin D

Volumn , Issue , 2011, Pages 193-209

  Dowd, Diane R ^a   MacDonald, Paul N ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860379233     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10010-1     Document Type: Chapter

References (158)

1. Owen T.A., Aronow M.S., Barone L.M., Bettencourt B., Stein G.S., Lian J.B. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 1991, 128:1496-1504.
2. 3. Proc. Natl. Acad. Sci. USA 1983, 80:5908-5911.
3. Sutton A.L., MacDonald P.N. Vitamin D: more than a "bone-a-fide" hormone. Mol. Endocrinol. 2003, 17:777-791.
4. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 2008, 29:726-776.
5. Kurokawa R., Yu V.C., Naar A., Kyakumoto S., Han Z., Silverman S., et al. Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev. 1993, 7:1423-1435.
6. Lemon B.D., Freedman L.P. Selective effects of ligands on vitamin D3 receptor- and retinoid x receptor-mediated gene activation in vivo. Mol. Cell. Biol. 1996, 16:1006-1016.
7. Tasset D., Tora L., Fromental C., Scheer E., Chambon P. Distinct classes of transcriptional activating domains function by different mechanisms. Cell 1990, 62:1177-1187.
8. Meyer M.-E., Gronemeyer H., Turcotte B., Bocquel M.-T., Tasset D., Chambon P. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 1989, 57:433-442.
9. McKenna N.J., Cooney A.J., DeMayo F.J., Downes M., Glass C.K., Lanz R.B., et al. Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas. Mol. Endocrinol. 2009, 23:740-746.
10. MacDonald P.N., Sherman D.R., Dowd D.R., Jefcoat S.C., DeLisle R.K. The vitamin D receptor interacts with general transcription factor IIB. J. Biol. Chem. 1995, 270:4748-4752.
11. Blanco J.C.G., Wang I.-M., Tsai S.Y., Tsai M.-J., O'Malley B.W., Jurutka P.W., et al. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc. Natl. Acad. Sci. USA 1995, 92:1535-1539.
12. Onate S.A., Tsai S.Y., Tsai M.-J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995, 270:1354-1357.
13. Masuyama H., Brownfield C.M., St.-Arnaud R., MacDonald P.N. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol. Endocrinol. 1997, 11:1507-1517.
14. Kraichely D.M., Collins J., DeLisle R.K., MacDonald P.N. The autonomous transactivation domain in helix H3 of the vitamin D receptor is required for transactivation and coactivator interaction. J. Biol. Chem 1999, 274:14352-14358.
15. Gill R.K., Bell N.H. Steroid receptor co-activator-1 mediates 1,25-dihydroxyvitamin D(3)-stimulated alkaline phosphatase in human osteosarcoma cells. Calcif. Tissue Int 2000, 66:370-374.
16. Hong H., Kohli K., Trivedi A., Johnson D.L., Stallcup M.R. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. USA 1996, 93:4948-4952.
17. Voegel J.J., Heine M.J., Zechel C., Chambon P., Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. Embo J. 1996, 15:3667-3675.
18. Li H., Gomes P.J., Chen J.D. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc. Natl. Acad. Sci. USA 1997, 94:8479-8484.
19. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997, 277:965-968.
20. Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., et al. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 1997, 90:569-580.
21. Takeshita A., Cardona G.R., Koibuchi N., Suen C.S., Chin W.W. TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J. Biol. Chem. 1997, 272:27629-27634.
22. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., et al. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 1997, 387:677-684.
23. Xu J., Wu R.C., O'Malley B.W. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat. Rev. Cancer 2009, 9:615-630.
24. Onate S.A., Boonyaratanakornkit V., Spencer T.E., Tsai S.Y., Tsai M.J., Edwards D.P., et al. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J. Biol. Chem. 1998, 273:12101-12108.
25. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997, 387:733-736.
26. McInerney E.M., Rose D.W., Flynn S.E., Westin S., Mullen T.M., Krones A., et al. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev. 1998, 12:3357-3368.
27. Ding X.F., Anderson C.M., Ma H., Hong H., Uht R.M., Kushner P.J., et al. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol. Endocrinol. 1998, 12:302-313.
28. Leers J., Treuter E., Gustafsson J.A. Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TIF2. Mol. Cell Biol. 1998, 18:6001-6013.
29. Bikle D.D., Teichert A., Arnold L.A., Uchida Y., Elias P.M., Oda Y. Differential regulation of epidermal function by VDR coactivators. J. Steroid Biochem. Mol. Biol. 2010, 121:308-313.
30. Leo C., Li H., Chen J.D. Differential mechanisms of nuclear receptor regulation by receptor-associated coactivator 3. J. Biol. Chem. 2000, 275:5976-5982.
31. 3 receptor regulate osteocalcin gene expression. Mol. Endocrinol. 1989, 3:635-644.
32. Rochel N., Wurtz J.M., Mitschler A., Klaholz B., Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell 2000, 5:173-179.
33. 3 signalling. Nature 1992, 355:446-449.
34. 3-activated expression of the rat osteocalcin gene. Mol. Cell Biol. 1993, 13:5907-5917.
35. Nakajima S., Hsieh J.-C., MacDonald P.N., Galligan M.A., Haussler C.A., Whitfield G.K., et al. The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element. Mol. Endocrinol. 1994, 8:159-172.
36. Danielian P.S., White R., Lees J.A., Parker M.G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. Embo J. 1992, 11:1025-1033.
37. Renaud J.-P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 1995, 378:681-689.
38. Feng W., Ribeiro R.C., Wagner R.L., Nguyen H., Apriletti J.W., Fletterick R.J., et al. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 1998, 280:1747-1749.
39. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 1998, 395:137-143.
40. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D., et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 1998, 12:3343-3356.
41. Pathrose P., Barmina O., Chang C.Y., McDonnell D.P., Shevde N.K., Pike J.W. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors. J. Bone Miner. Res. 2002, 17:2196-2205.
42. Choi J.K., Howe L.J. Histone acetylation: truth of consequences?. Biochem. Cell Biol. 2009, 87:139-150.
43. Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J., Mizzen C.A., et al. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 1997, 389:194-198.
44. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996, 87:953-959.
45. Bannister A.J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 1996, 384:641-643.
46. Yang X.J., Ogryzko V.V., Nishikawa J., Howard B.H., Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 1996, 382:319-324.
47. Voegel J.J., Heine M.J., Tini M., Vivat V., Chambon P., Gronemeyer H. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 1998, 17:507-519.
48. Korzus E., Torchia J., Rose D.W., Xu L., Kurokawa R., McInerney E.M., et al. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 1998, 279:703-707.
49. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996, 85:403-414.
50. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., et al. Role of CBP/P300 in nuclear receptor signalling. Nature 1996, 383:99-103.
51. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., et al. Regulation of transcription by a protein methyltransferase. Science 1999, 284:2174-2177.
52. Koh S.S., Chen D., Lee Y.H., Stallcup M.R. Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J. Biol. Chem. 2001, 276:1089-1098.
53. Feng Q., Yi P., Wong J., O'Malley B.W. Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly. Mol. Cell Biol. 2006, 26:7846-7857.
54. Naeem H., Cheng D., Zhao Q., Underhill C., Tini M., Bedford M.T., et al. The activity and stability of the transcriptional coactivator p/CIP/SRC-3 are regulated by CARM1-dependent methylation. Mol. Cell Biol. 2007, 27:120-134.
55. Xu J., Qiu Y., DeMayo F.J., Tsai S.Y., Tsai M.J., O'Malley B.W. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 1998, 279:1922-1925.
56. Gehin M., Mark M., Dennefeld C., Dierich A., Gronemeyer H., Chambon P. The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol. Cell Biol. 2002, 22:5923-5937.
57. Yuan Y., Liao L., Tulis D.A., Xu J. Steroid receptor coactivator-3 is required for inhibition of neointima formation by estrogen. Circulation 2002, 105:2653-2659.
58. Xu J., Liao L., Ning G., Yoshida-Komiya H., Deng C., O'Malley B.W. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl. Acad. Sci. USA 2000, 97:6379-6384.
59. Kuang S.Q., Liao L., Wang S., Medina D., O'Malley B.W., Xu J. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis. Cancer Res. 2005, 65:7993-8002.
60. Kuang S.Q., Liao L., Zhang H., Lee A.V., O'Malley B.W., Xu J. AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice. Cancer Res. 2004, 64:1875-1885.
61. Weiss R.E., Xu J., Ning G., Pohlenz J., O'Malley B.W., Refetoff S. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. Embo J. 1999, 18:1900-1904.
62. Issa L.L., Leong G.M., Barry J.B., Sutherland R.L., Eisman J.A. Glucocorticoid receptor-interacting protein-1 and receptor-associated coactivator-3 differentially interact with the vitamin D receptor (VDR) and regulate VDR-retinoid X receptor transcriptional cross-talk. Endocrinology 2001, 142:1606-1615.
63. Liao L., Chen X., Wang S., Parlow A.F., Xu J. Steroid receptor coactivator 3 maintains circulating insulin-like growth factor I (IGF-I) by controlling IGF-binding protein 3 expression. Mol. Cell Biol. 2008, 28:2460-2469.
64. Hawker N.P., Pennypacker S.D., Chang S.M., Bikle D.D. Regulation of human epidermal keratinocyte differentiation by the vitamin D receptor and its coactivators DRIP205, SRC2, and SRC3. J. Invest. Dermatol. 2007, 127:874-880.
65. Oda Y., Sihlbom C., Chalkley R.J., Huang L., Rachez C., Chang C.P., et al. Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in vitamin D receptor transactivation during keratinocyte differentiation. Mol. Endocrinol. 2003, 17:2329-2339.
66. Oda Y., Uchida Y., Moradian S., Crumrine D., Elias P.M., Bikle D.D. Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation. J. Invest. Dermatol. 2009, 129:1367-1378.
67. Rachez C., Suldan Z., Ward J., Chang C.P., Burakov D., Erdjument-Bromage H., et al. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev. 1998, 12:1787-1800.
68. Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M., Naar A.M., et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 1999, 398:824-828.
69. Fondell J.D., Ge H., Roeder R.G. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl. Acad. Sci. USA 1996, 93:8329-8333.
70. Jiang Y.W., Veschambre P., Erdjument-Bromage H., Tempst P., Conaway J.W., Conaway R.C., et al. Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways. Proc. Natl. Acad. Sci. USA 1998, 95:8538-8543.
71. Naar A.M., Beaurang P.A., Zhou S., Abraham S., Solomon W., Tjian R. Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature 1999, 398:828-832.
72. Rachez C., Freedman L.P. Mediator complexes and transcription. Curr. Opin. Cell Biol. 2001, 13:274-280.
73. Chiba N., Suldan Z., Freedman L.P., Parvin J.D. Binding of liganded vitamin D receptor to the vitamin D receptor interacting protein coactivator complex induces interaction with RNA polymerase II holoenzyme. J. Biol. Chem. 2000, 275:10719-10722.
74. Sun X., Zhang Y., Cho H., Rickert P., Lees E., Lane W., et al. NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription. Mol. Cell 1998, 2:213-222.
75. Yudkovsky N., Ranish J.A., Hahn S. A transcription reinitiation intermediate that is stabilized by activator. Nature 2000, 408:225-229.
76. Rachez C., Gamble M., Chang C.P., Atkins G.B., Lazar M.A., Freedman L.P. The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol. Cell Biol. 2000, 20:2718-2726.
77. Cantin G.T., Stevens J.L., Berk A.J. Activation domain-mediator interactions promote transcription preinitiation complex assembly on promoter DNA. Proc. Natl. Acad. Sci. USA 2003, 100:12003-12008.
78. Barletta F., Freedman L.P., Christakos S. Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex. Mol. Endocrinol. 2002, 16:301-314.
79. 3 receptor. J. Biol. Chem. 1999, 274:16838-16845.
80. Oda Y., Chalkley R.J., Burlingame A.L., Bikle D.D. The transcriptional coactivator DRIP/Mediator complex is involved in vitamin D receptor function and regulates keratinocyte proliferation and differentiation. J. Invest. Dermatol. 2010.
81. Ito M., Yuan C.X., Okano H.J., Darnell R.B., Roeder R.G. Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action. Mol. Cell 2000, 5:683-693.
82. Zhu Y., Qi C., Jia Y., Nye J.S., Rao M.S., Reddy J.K. Deletion of PBP/PPARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality. J. Biol. Chem. 2000, 275:14779-14782.
83. Ge K., Guermah M., Yuan C.X., Ito M., Wallberg A.E., Spiegelman B.M., et al. Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. Nature 2002, 417:563-567.
84. Oda Y., Ishikawa M.H., Hawker N.P., Yun Q.C., Bikle D.D. Differential role of two VDR coactivators, DRIP205 and SRC-3, in keratinocyte proliferation and differentiation. J. Steroid. Biochem. Mol. Biol. 2007, 103:776-780.
85. Oda Y., Sihlbom C., Chalkley R.J., Huang L., Rachez C., Chang C.P., et al. Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in VDR transactivation during keratinocyte differentiation. J. Steroid. Biochem. Mol. Biol. 2004, 89-90:273-276.
86. Baudino T.A., Kraichely D.M., Jefcoat S.C., Winchester S.K., Partridge N.C., MacDonald P.N. Isolation and characterization of a novel coactivator protein, NCoA-62, involved in vitamin D-mediated transcription. J. Biol. Chem. 1998, 273:16434-16441.
87. Wieland C., Mann S., Besser H., Saumweber H. The Drosophila nuclear protein Bx42, which is found in many puffs on polytene chromosomes, is highly charged. Chromosoma 1992, 101:517-525.
88. Dahl R., Wani B., Hayman M.J. The Ski oncoprotein interacts with Skip, the human homolog of Drosophila Bx42. Oncogene 1998, 16:1579-1586.
89. Zhou S., Fujimuro M., Hsieh J.J., Chen L., Miyamoto A., Weinmaster G., et al. SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC to facilitate NotchIC function. Mol. Cell Biol. 2000, 20:2400-2410.
90. Leong G.M., Subramaniam N., Figueroa J., Flanagan J.L., Hayman M.J., Eisman J.A., et al. Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription. J. Biol. Chem. 2001, 276:18243-18248.
91. Kim Y.J., Noguchi S., Hayashi Y.K., Tsukahara T., Shimizu T., Arahata K. The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression. Hum. Mol. Genet. 2001, 10:1129-1139.
92. Prathapam T., Kuhne C., Banks L. The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity. Oncogene 2001, 20:7677-7685.
93. Fukuda S., Yamasaki Y., Iwaki T., Kawasaki H., Akieda S., Fukuchi N., et al. Characterization of the biological functions of a transcription factor, c-myc intron binding protein 1 (MIBP1). J. Biochem. (Tokyo) 2002, 131:349-357.
94. Prathapam T., Kuhne C., Banks L. Skip interacts with the retinoblastoma tumor suppressor and inhibits its transcriptional repression activity. Nucleic Acids Res. 2002, 30:5261-5268.
95. Zhang C., Baudino T.A., Dowd D.R., Tokumaru H., Wang W., MacDonald P.N. Ternary complexes and cooperative interplay between NCoA-62/Ski-interacting protein and steroid receptor coactivators in vitamin D receptor-mediated transcription. J. Biol. Chem. 2001, 276:40614-40620.
96. Barry J.B., Leong G.M., Church W.B., Issa L.L., Eisman J.A., Gardiner E.M. Interactions of SKIP/NCoA-62, TFIIB, and retinoid X receptor with vitamin D receptor helix H10 residues. J. Biol. Chem. 2003, 278:8224-8228.
97. Leong G.M., Subramaniam N., Issa L.L., Barry J.B., Kino T., Driggers P.H., et al. Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with N-CoR/SMRT and p300. Biochem. Biophys. Res. Commun. 2004, 315:1070-1076.
98. Zhang C., Dowd D.R., Staal A., Gu C., Lian J.B., van Wijnen A.J., et al. Nuclear coactivator-62 kDa/Ski-interacting protein is a nuclear matrix-associated coactivator that may couple vitamin D receptor-mediated transcription and RNA splicing. J. Biol. Chem. 2003, 278:35325-35336.
99. Orgryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996, 87:953-959.
100. Auboeuf D., Honig A., Berget S.M., O'Malley B.W. Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 2002, 298:416-419.
101. Pandit S., Wang D., Fu X.D. Functional integration of transcriptional and RNA processing machineries. Curr. Opin. Cell Biol. 2008, 20:260-265.
102. Bentley D.L. Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors. Curr Opin. Cell Biol. 2005, 17:251-256.
103. Monsalve M., Wu Z., Adelmant G., Puigserver P., Fan M., Spiegelman B.M. Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol. Cell 2000, 6:307-316.
104. Makarov E.M., Makarova O.V., Urlaub H., Gentzel M., Will C.L., Wilm M., et al. Small nuclear ribonucleoprotein remodeling during catalytic activation of the spliceosome. Science 2002, 298:2205-2208.
105. Mintz P.J., Patterson S.D., Neuwald A.F., Spahr C.S., Spector D.L. Purification and biochemical characterization of interchromatin granule clusters. Embo J. 1999, 18:4308-4320.
106. Neubauer G., King A., Rappsilber J., Calvio C., Watson M., Ajuh P., et al. Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat. Genet. 1998, 20:46-50.
107. Yanagisawa J., Yanagi Y., Masuhiro Y., Suzawa M., Watanabe M., Kashiwagi K., et al. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 1999, 283:1317-1321.
108. Tolon R.M., Castillo A.I., Jimenez-Lara A.M., Aranda A. Association with Ets-1 causes ligand- and AF2-independent activation of nuclear receptors. Mol. Cell Biol. 2000, 20:8793-8802.
109. Kitagawa H., Fujiki R., Yoshimura K., Mezaki Y., Uematsu Y., Matsui D., et al. The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 2003, 113:905-917.
110. Morris C.A., Mervis C.B. Williams syndrome and related disorders. Annu. Rev. Genomics Hum. Genet. 2000, 1:461-484.
111. Kato S., Fujiki R., Kim M.S., Kitagawa H. Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC. J. Steroid Biochem. Mol. Biol. 2007, 103:372-380.
112. Kato S., Fujiki R., Kitagawa H. Vitamin D receptor (VDR) promoter targeting through a novel chromatin remodeling complex. J. Steroid Biochem. Mol. Biol. 2004, 89-90:173-178.
113. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839.
114. Savkur R.S., Bramlett K.S., Stayrook K.R., Nagpal S., Burris T.P. Coactivation of the human vitamin D receptor by the peroxisome proliferator-activated receptor gamma coactivator-1 alpha. Mol. Pharmacol. 2005, 68:511-517.
115. Endo I., Inoue D., Mitsui T., Umaki Y., Akaike M., Yoshizawa T., et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003, 144:5138-5144.
116. Narvaez C.J., Matthews D., Broun E., Chan M., Welsh J. Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology 2009, 150:651-661.
117. Lekanne Deprez R.H., Riegman P.H., Groen N.A., Warringa U.L., van Biezen N.A., Molijn A.C., et al. Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene 1995, 10:1521-1528.
118. Sutton A.L., Zhang X., Ellison T.I., MacDonald P.N. The 1,25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation. Mol. Endocrinol. 2005, 19:2234-2244.
119. Meester-Smoor M.A., Vermeij M., van Helmond M.J., Molijn A.C., van Wely K.H., Hekman A.C., et al. Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton. Mol. Cell Biol. 2005, 25:4229-4236.
120. Zhang X., Dowd D.R., Moore M.C., Kranenburg T.A., Meester-Smoor M.A., Zwarthoff E.C., et al. Meningioma 1 is required for appropriate osteoblast proliferation, motility, differentiation, and function. J. Biol. Chem. 2009, 284:18174-18183.
121. Ochiai E., Kitagawa H., Takada I., Fujiyama S., Sawatsubashi S., Kim M.S., et al. CDP/cut is an osteoblastic coactivator of the vitamin D receptor (VDR). J. Bone Miner. Res. 2010, 25:1157-1166.
122. Perissi V., Jepsen K., Glass C.K., Rosenfeld M.G. Deconstructing repression: evolving models of co-repressor action. Nat. Rev. Genet. 2010, 11:109-123.
123. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995, 377:454-457.
124. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995, 377:397-404.
125. Hu X., Lazar M.A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 1999, 402:93-96.
126. Perissi V., Staszewski L.M., McInerney E.M., Kurokawa R., Krones A., Rose D.W., et al. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 1999, 13:3198-3208.
127. Kim J.Y., Son Y.L., Lee Y.C. Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor. Mol. Endocrinol. 2009, 23:251-264.
128. Tagami T., Lutz W.H., Kumar R., Jameson J.L. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem. Biophys. Res. Commun. 1998, 253:358-363.
129. Sanchez-Martinez R., Zambrano A., Castillo A.I., Aranda A. Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers. Mol Cell Biol. 2008, 28:3817-3829.
130. Nagy L., Kao H.Y., Love J.D., Li C., Banayo E., Gooch J.T., et al. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 1999, 13:3209-3216.
131. Xu H.E., Stanley T.B., Montana V.G., Lambert M.H., Shearer B.G., Cobb J.E., et al. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 2002, 415:813-817.
132. Lempiainen H., Molnar F., Macias Gonzalez M., Perakyla M., Carlberg C. Antagonist- and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein. Mol. Endocrinol. 2005, 19:2258-2272.
133. Perissi V., Scafoglio C., Zhang J., Ohgi K.A., Rose D.W., Glass C.K., et al. TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. Mol. Cell 2008, 29:755-766.
134. Toropainen S., Vaisanen S., Heikkinen S., Carlberg C. The down-regulation of the human MYC gene by the nuclear hormone 1alpha,25-dihydroxyvitamin D3 is associated with cycling of corepressors and histone deacetylases. J. Mol. Biol. 2010, 400:284-294.
135. Li M., Chiba H., Warot X., Messaddeq N., Gerard C., Chambon P., et al. RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 2001, 128:675-688.
136. Zarach J.M., Beaudoin G.M., Coulombe P.A., Thompson C.C. The co-repressor hairless has a role in epithelial cell differentiation in the skin. Development 2004, 131:4189-4200.
137. Miller J., Djabali K., Chen T., Liu Y., Ioffreda M., Lyle S., et al. Atrichia caused by mutations in the vitamin D receptor gene is a phenocopy of generalized atrichia caused by mutations in the hairless gene. J. Invest. Dermatol. 2001, 117:612-617.
138. Xie Z., Chang S., Oda Y., Bikle D.D. Hairless suppresses vitamin D receptor transactivation in human keratinocytes. Endocrinology 2006, 147:314-323.
139. Hsieh J.C., Sisk J.M., Jurutka P.W., Haussler C.A., Slater S.A., Haussler M.R., et al. Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. J. Biol. Chem. 2003, 278:38665-38674.
140. Potter G.B., Beaudoin G.M., DeRenzo C.L., Zarach J.M., Chen S.H., Thompson C.C. The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor. Genes Dev. 2001, 15:2687-2701.
141. Moraitis A.N., Giguere V., Thompson C.C. Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants. Mol. Cell Biol. 2002, 22:6831-6841.
142. Teichert A., Arnold L.A., Otieno S., Oda Y., Augustinaite I., Geistlinger T.R., et al. Quantification of the vitamin D receptor-coregulator interaction. Biochemistry 2009, 48:1454-1461.
143. Djabali K., Christiano A.M. Hairless contains a novel nuclear matrix targeting signal and associates with histone deacetylase 3 in nuclear speckles. Differentiation 2004, 72:410-418.
144. Wang J., Malloy P.J., Feldman D. Interactions of the vitamin D receptor with the corepressor hairless: analysis of hairless mutants in atrichia with papular lesions. J. Biol. Chem. 2007, 282:25231-25239.
145. Malloy P.J., Wang J., Jensen K., Feldman D. Modulation of vitamin D receptor activity by the corepressor hairless: differential effects of hairless isoforms. Endocrinology 2009, 150:4950-4957.
146. Panteleyev A.A., Paus R., Ahmad W., Sundberg J.P., Christiano A.M. Molecular and functional aspects of the hairless (hr) gene in laboratory rodents and humans. Exp. Dermatol. 1998, 7:249-267.
147. Dressel U., Thormeyer D., Altincicek B., Paululat A., Eggert M., Schneider S., et al. Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol. Cell Biol. 1999, 19:3383-3394.
148. Polly P., Herdick M., Moehren U., Baniahmad A., Heinzel T., Carlberg C. VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J. 2000, 14:1455-1463.
149. Eckey M., Hong W., Papaioannou M., Baniahmad A. The nucleosome assembly activity of NAP1 is enhanced by Alien. Mol. Cell Biol. 2007, 27:3557-3568.
150. Carlberg C., Seuter S. Dynamics of nuclear receptor target gene regulation. Chromosoma 2010, 119:479-484.
151. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103:843-852.
152. Burakov D., Crofts L.A., Chang C.P., Freedman L.P. Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor. J. Biol. Chem. 2002, 277:14359-14362.
153. Sharma D., Fondell J.D. Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo. Proc. Natl. Acad. Sci. USA 2002, 99:7934-7939.
154. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.
155. Malinen M., Saramaki A., Ropponen A., Degenhardt T., Vaisanen S., Carlberg C. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3. Nucleic Acids Res. 2008, 36:121-132.
156. Lonard D.M., O'Malley B.W. Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol. Cell 2007, 27:691-700.
157. Perissi V., Rosenfeld M.G. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol. 2005, 6:542-554.
158. Perissi V., Aggarwal A., Glass C.K., Rose D.W., Rosenfeld M.G. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 2004, 116:511-526.